TW202317065A - Surface modified retinoid immersion porous silica - Google Patents

Surface modified retinoid immersion porous silica Download PDF

Info

Publication number
TW202317065A
TW202317065A TW111123770A TW111123770A TW202317065A TW 202317065 A TW202317065 A TW 202317065A TW 111123770 A TW111123770 A TW 111123770A TW 111123770 A TW111123770 A TW 111123770A TW 202317065 A TW202317065 A TW 202317065A
Authority
TW
Taiwan
Prior art keywords
retinoid
porous silica
polyethoxylated
loaded
modified
Prior art date
Application number
TW111123770A
Other languages
Chinese (zh)
Inventor
權純軾
趙桓一
宋榮淑
Original Assignee
南韓商Lg生活健康股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 南韓商Lg生活健康股份有限公司 filed Critical 南韓商Lg生活健康股份有限公司
Publication of TW202317065A publication Critical patent/TW202317065A/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • A61K8/0279Porous; Hollow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585Organosilicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00Silicon; Compounds thereof
    • C01B33/113Silicon oxides; Hydrates thereof
    • C01B33/12Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • C01B33/18Preparation of finely divided silica neither in sol nor in gel form; After-treatment thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/412Microsized, i.e. having sizes between 0.1 and 100 microns
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60Particulates further characterized by their structure or composition
    • A61K2800/61Surface treated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70Biological properties of the composition as a whole
    • A61K2800/72Hypo-allergenic
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/60Particles characterised by their size
    • C01P2004/61Micrometer sized, i.e. from 1-100 micrometer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a surface-modified retinoid-impregnated porous silica. More specifically, the present invention is characterized in that porous silica is impregnated with a polyethoxylated retinoid and then surface-treated with a silane-based compound to increase the impregnation efficiency of the retinoid and improve sustained release efficiency, and thus can be used as an active ingredient in functional cosmetics having improved stability and safety.

Description

表面改性的類視黃醇負載多孔二氧化矽Surface-modified retinoid-loaded porous silica

本發明涉及穩定性和安全性得到改善的低刺激的表面改性的類視黃醇負載多孔二氧化矽。The present invention relates to low irritation surface modified retinoid loaded porous silica with improved stability and safety.

維生素A或其衍生物是目前已知的改善老化皮膚的代表性物質,並且含有它們的產品正在大量銷售。據悉,維生素A或其衍生物使皮膚內成纖維細胞的增殖和膠原蛋白合成增加,並被廣泛用作皺紋功能性化妝品的有效成分。然而,維生素A是脂溶性的,存在因光、氧、熱、脂質過氧化物而不穩定的缺點,因此穩定化技術是必須的,並且產品開發時,容器也要使用阻斷光和氧的容器才能確保穩定性。另外,過量的維生素A或其衍生物是可以通過陽光增加皮膚感受性的物質。當消費者使用包含維生素A或其衍生物的化妝品時,在皮膚上會以皮膚變紅、紅斑、刺痛、搔癢等的多種形式顯現於皮膚。Vitamin A or its derivatives are currently known representative substances for improving aging skin, and products containing them are being sold in large quantities. It is reported that vitamin A or its derivatives increase the proliferation of fibroblasts and collagen synthesis in the skin, and are widely used as active ingredients in functional cosmetics for wrinkles. However, vitamin A is fat-soluble and has the disadvantage of being unstable due to light, oxygen, heat, and lipid peroxides. Therefore, stabilization technology is necessary, and during product development, containers that block light and oxygen should also be used. Containers ensure stability. In addition, excessive vitamin A or its derivatives are substances that can increase skin sensitivity to sunlight. When consumers use cosmetics containing vitamin A or its derivatives, it will appear on the skin in various forms such as skin redness, erythema, tingling, itching, and the like.

為了改善這種維生素A及其衍生物的穩定性和安全性,在韓國註冊專利(10-1314100)等中努力通過利用脂質體等的多種藥物遞送系統來改善穩定性/安全性。然而,對於這種藥物遞送載體,不僅有效成分的負載效率顯著低,而且在化妝品劑型內的其他輔助成分和劑型製備製程中會出現藥物遞送載體的形式暫時崩潰或部分崩潰的現象。因此,類視黃醇的穩定性改善效果不大,並且由緩釋型釋放引起的安全性改善效果也仍然不足。In order to improve the stability and safety of such vitamin A and its derivatives, efforts have been made to improve stability/safety by utilizing various drug delivery systems such as liposomes in Korean Registered Patent (10-1314100) and the like. However, for this kind of drug delivery carrier, not only the loading efficiency of the active ingredient is significantly low, but also the form of the drug delivery carrier may temporarily collapse or partially collapse during the preparation process of other auxiliary ingredients in the cosmetic dosage form and the dosage form. Therefore, the effect of improving the stability of retinoids is not large, and the effect of improving safety by sustained-release type release is still insufficient.

[技術課題][Technical Issues]

本發明的目的是提供穩定性/安全性得到改善的低刺激的類視黃醇負載多孔二氧化矽及其製備方法。The object of the present invention is to provide a low-irritation retinoid-loaded porous silica with improved stability/safety and a preparation method thereof.

本發明的另一個目的是提供一種化妝料組合物,其包含上述低刺激的類視黃醇負載多孔二氧化矽。 [解決方案] Another object of the present invention is to provide a cosmetic composition comprising the above-mentioned low-irritation retinoid-loaded porous silica. [solution]

為了實現上述目的,本發明提供一種類視黃醇負載多孔二氧化矽,其負載有聚乙氧基化類視黃醇並且由矽烷類化合物進行了表面改性。In order to achieve the above object, the present invention provides a retinoid-loaded porous silica, which is loaded with polyethoxylated retinoid and surface-modified by silane compounds.

本發明還提供一種表面改性的類視黃醇負載多孔二氧化矽的製備方法,包括: 混合聚乙氧基化類視黃醇溶液和多孔二氧化矽以將聚乙氧基化類視黃醇負載於多孔二氧化矽內的步驟;以及 使負載有聚乙氧基化類視黃醇的多孔二氧化矽和矽烷類化合物反應以對多孔二氧化矽的表面進行改性的步驟。 The present invention also provides a preparation method of surface-modified retinoid-loaded porous silica, comprising: a step of mixing the polyethoxylated retinoid solution and the porous silica to load the polyethoxylated retinoid in the porous silica; and A step of modifying the surface of the porous silica by reacting the polyethoxylated retinoid-loaded porous silica with a silane compound.

本發明還提供一種化妝料組合物,其包含上述的表面改性的類視黃醇負載多孔二氧化矽。 [發明的效果] The present invention also provides a cosmetic composition comprising the above-mentioned surface-modified retinoid-loaded porous silica. [Effect of the invention]

本發明可以通過將聚乙氧基化形式的類視黃醇負載於多孔二氧化矽然後用矽烷類化合物進行表面處理來提高類視黃醇的負載效率,改善緩釋性釋放效率,從而用作穩定性和安全性得到改善的功能性化妝品的有效成分。The present invention can improve the loading efficiency of retinoids by loading polyethoxylated retinoids on porous silicon dioxide and then surface-treating them with silane compounds, and improve the sustained-release release efficiency, so as to be used as Active ingredients for functional cosmetics with improved stability and safety.

以下,具體說明本發明的構成。Hereinafter, the structure of this invention is demonstrated concretely.

本發明涉及一種類視黃醇負載多孔二氧化矽,其負載有聚乙氧基化類視黃醇並且由矽烷類化合物進行了表面改性。The invention relates to a retinoid-loaded porous silicon dioxide, which is loaded with polyethoxylated retinoid and surface-modified by silane compounds.

本發明的特徵在於,對於維生素A衍生物即類視黃醇,1) 為了改善類視黃醇的穩定性,使用具有不易因化妝品劑型內的其他成分而發生分解/變性,並且可以通過減少類視黃醇類的光/氧的暴露來提高穩定性,並且與其他藥物遞送載體相比可以負載高含量的類視黃醇的優點的多孔二氧化矽作為載體,並且2) 為了改善類視黃醇安全性,通過用矽烷類化合物對多孔二氧化矽表面進行表面處理來以緩釋型溶出類視黃醇。The present invention is characterized in that, for vitamin A derivatives, ie, retinoids, 1) in order to improve the stability of retinoids, it is difficult to decompose/denature due to other ingredients in the cosmetic formulation, and it can be reduced by reducing the retinoids. Light/oxygen exposure of retinoids to improve stability, and porous silica as a carrier that can load high content of retinoids compared to other drug delivery vehicles, and 2) in order to improve retinoids Alcohol safety, by surface-treating the surface of porous silica with silane compounds to dissolve retinoids in a sustained release type.

根據本發明的一個具體例,對於類視黃醇的釋放行為,利用弗朗茲擴散池 (Franze diffusion cell)比較了O/W劑型中本發明的表面改性的類視黃醇負載多孔二氧化矽和未負載於多孔二氧化矽的類視黃醇,並且為了比較類視黃醇的安全性,通過表面改性的類視黃醇負載多孔二氧化矽粉末的HET-CAM測試和消費者品評確認了刺激指數。其結果,在25 ℃和40 ℃下表面改性的類視黃醇負載多孔二氧化矽粉末應用劑型即使在16周中也穩定,並且類視黃醇溶出量依賴於矽烷類化合物的濃度而減少,使類視黃醇緩慢溶出,從而確認了作為緩釋型製劑的應用可能性。According to a specific example of the present invention, for the release behavior of retinoids, the surface-modified retinoid-loaded porous dioxide of the present invention in O/W dosage forms was compared using a Franz diffusion cell. Silicon and retinoids not loaded on porous silica, and to compare the safety of retinoids by HET-CAM testing and consumer evaluation of surface-modified retinoid-loaded porous silica powders Stimulus index confirmed. As a result, the application dosage form of the surface-modified retinoid-loaded porous silica powder was stable even for 16 weeks at 25°C and 40°C, and the amount of retinoid eluted was reduced depending on the concentration of the silane compound , to slowly dissolve the retinoid, thereby confirming the possibility of application as a sustained-release preparation.

上述聚乙氧基化類視黃醇可以使用聚乙氧基化視黃醯胺(polyethoxylated retinamide)。As the above-mentioned polyethoxylated retinoid, polyethoxylated retinamide (polyethoxylated retinamide) can be used.

上述多孔二氧化矽可以具有1至50 μm的直徑尺寸。The aforementioned porous silica may have a diameter size of 1 to 50 μm.

上述矽烷類化合物可以單獨使用三乙氧基辛基矽烷 (Triethoxycaprylylsilane)、胺丙基三乙氧基矽烷 (Aminopropyl Triethoxysilane)、縮水甘油醚氧基丙基三甲氧基矽烷 (Glycidoxypropyl Trimethoxysilane)、異丁基三乙氧基矽烷 (Isobutyltriethoxysilane)、全氟辛基乙基三乙氧基矽烷 (Perfluorooctylethyl Triethoxysilane)、全氟辛基三乙氧基矽烷 (Perfluorooctyl Triethoxysilane)、硬脂基三乙氧基矽烷 (Stearyl Triethoxysilane)、甲基三乙氧基矽烷 (Methyltriethoxysilane)、PEG-8甲基醚三乙氧基矽烷 (PEG-8 Methyl Ether Triethoxysilane)、乙烯基乙氧基矽烷 (Vinyltriethoxysilane)等,或者可以使用兩種以上。The above-mentioned silane compounds can be independently used triethoxycaprylylsilane (Triethoxycaprylylsilane), aminopropyl triethoxysilane (Aminopropyl Triethoxysilane), glycidyl etheroxypropyl trimethoxysilane (Glycidoxypropyl Trimethoxysilane), isobutyl Isobutyltriethoxysilane, Perfluorooctylethyl Triethoxysilane, Perfluorooctyl Triethoxysilane, Stearyl Triethoxysilane ), Methyltriethoxysilane, PEG-8 Methyl Ether Triethoxysilane, Vinylethoxysilane, etc., or two or more .

本發明還涉及一種表面改性的類視黃醇負載多孔二氧化矽的製備方法,包括: 混合聚乙氧基化類視黃醇溶液和多孔二氧化矽以將聚乙氧基化類視黃醇負載於多孔二氧化矽內的步驟;以及 使負載有聚乙氧基化類視黃醇的多孔二氧化矽和矽烷類化合物反應以對多孔二氧化矽的表面進行改性的步驟。 The present invention also relates to a preparation method of surface-modified retinoid-loaded porous silica, comprising: a step of mixing the polyethoxylated retinoid solution and the porous silica to load the polyethoxylated retinoid in the porous silica; and A step of modifying the surface of the porous silica by reacting the polyethoxylated retinoid-loaded porous silica with a silane compound.

本發明的表面改性的類視黃醇負載多孔二氧化矽的特徵在於,通過聚乙二醇化 (PEGylation)將具有親水部的類視黃醇負載於多孔二氧化矽,然後通過熱處理用疏水性的矽烷類化合物進行表面塗覆而製備。The surface-modified retinoid-supported porous silica of the present invention is characterized in that a retinoid having a hydrophilic portion is supported on the porous silica by PEGylation, and then the hydrophobicity is reduced by heat treatment. prepared by surface coating of silane compounds.

如下分步驟具體說明本發明的表面改性的類視黃醇負載多孔二氧化矽的製備方法。The preparation method of the surface-modified retinoid-loaded porous silica of the present invention is described in detail as follows.

第1步驟是將聚乙氧基化類視黃醇負載於多孔二氧化矽的步驟。The first step is a step of loading polyethoxylated retinoid on porous silica.

為此,首先,在光阻斷條件下將聚乙氧基化類視黃醇均勻地溶解在溶劑中以製備類視黃醇溶液。For this, first, polyethoxylated retinoid was uniformly dissolved in a solvent under light-blocking conditions to prepare a retinoid solution.

相對於100重量%的表面改性的類視黃醇負載多孔二氧化矽,上述聚乙氧基化類視黃醇的混合量可以為0.5至20重量%、更具體地5至15重量%。當超出上述範圍時,未負載於多孔二氧化矽內而殘留的類視黃醇含量增加,因此經濟性可能降低。The above polyethoxylated retinoid may be mixed in an amount of 0.5 to 20% by weight, more specifically 5 to 15% by weight, relative to 100% by weight of the surface-modified retinoid-supported porous silica. When the above range is exceeded, the residual retinoid content that is not supported in the porous silica increases, and thus the economical efficiency may decrease.

上述溶劑可以使用甲醇或乙醇。上述溶劑的含量可以根據類視黃醇的含量在所屬技術領域中具有通常知識者的水平上適當調節,因此沒有特別限制。Methanol or ethanol can be used as the above-mentioned solvent. The content of the above-mentioned solvent can be appropriately adjusted according to the content of the retinoid at the level of those skilled in the art, and thus is not particularly limited.

當製備上述類視黃醇溶液時,可以根據需要進一步添加烴類油、酯油、天然油、矽油、抗氧化劑、光穩定劑、抗炎劑、防變色劑、紫外線阻斷劑、染料、顏料等。When preparing the above retinoid solution, hydrocarbon oils, ester oils, natural oils, silicone oils, antioxidants, light stabilizers, anti-inflammatory agents, anti-tarnish agents, UV blockers, dyes, pigments can be further added as needed wait.

接下來,將聚乙氧基化類視黃醇溶液緩慢投入到多孔二氧化矽中,利用混合機、例如亨舍爾混合機等在常溫下均勻混合10分鐘以上。Next, the polyethoxylated retinoid solution is slowly poured into the porous silica, and uniformly mixed at room temperature for more than 10 minutes using a mixer such as a Henschel mixer.

上述多孔二氧化矽可以具有1至50 μm的直徑尺寸。上述多孔二氧化矽的吸油量可以使用0.3至3 cc/g水平的原料。相對於100重量%的表面改性的類視黃醇負載多孔二氧化矽,上述多孔二氧化矽的混合量可以為50至99重量%、較佳地為60至99重量%、更佳地為65至94重量%。當超出上述範圍時,多孔二氧化矽粉末可製備成凝聚的形式,而不會形成均勻的粉末形式。當其分散在其他化妝品劑型中時,可對穩定性產生影響。The aforementioned porous silica may have a diameter size of 1 to 50 μm. The oil absorption of the above-mentioned porous silica can use a raw material at the level of 0.3 to 3 cc/g. With respect to 100% by weight of the surface-modified retinoid-loaded porous silica, the mixing amount of the above-mentioned porous silica may be 50 to 99% by weight, preferably 60 to 99% by weight, more preferably 65 to 94% by weight. When the above range is exceeded, the porous silica powder may be prepared in an agglomerated form without forming a uniform powder form. It can have an impact on stability when dispersed in other cosmetic formulations.

第2步驟是使用矽烷類化合物作為表面處理(改性)劑對負載有聚乙氧基化類視黃醇的多孔二氧化矽的表面進行改性的步驟。The second step is a step of modifying the surface of the porous silica loaded with polyethoxylated retinoid using a silane compound as a surface treatment (modification) agent.

將矽烷類化合物投入到在第1步驟中製備的負載有聚乙氧基化類視黃醇的多孔二氧化矽中,利用亨舍爾混合機均勻混合約10分鐘。接下來,為了表面處理,進行在40至120 ℃下反應30分鐘至5小時、更具體地在80至100 ℃下反應1小時至4小時的熱處理,然後冷卻,製備表面改性的類視黃醇負載多孔二氧化矽。當熱處理超出上述範圍時,在低溫下表面處理可能無法正常進行,並且高溫時可對類視黃醇變色以及其他物質的穩定性產生影響。Put the silane compound into the polyethoxylated retinoid-loaded porous silica prepared in the first step, and mix uniformly for about 10 minutes with a Henschel mixer. Next, for surface treatment, heat treatment of reacting at 40 to 120° C. for 30 minutes to 5 hours, more specifically, reacting at 80 to 100° C. for 1 hour to 4 hours, followed by cooling to prepare a surface-modified retinoid Alcohol-loaded porous silica. When the heat treatment exceeds the above range, the surface treatment may not be performed normally at low temperature, and the discoloration of retinoid and the stability of other substances may be affected at high temperature.

相對於100重量%的表面改性的類視黃醇負載多孔二氧化矽,上述矽烷類化合物的混合量可以為0.5至20重量%、更具體地1至15重量%。當超出上述範圍時,類視黃醇溶出量減少,類視黃醇的效果降低,或者當非常過量時,可能無法捕集在多孔二氧化矽內部而存在於二氧化矽表面。The compounding amount of the above-mentioned silane compound may be 0.5 to 20% by weight, more specifically 1 to 15% by weight, relative to 100% by weight of the surface-modified retinoid-supported porous silica. When the above range is exceeded, the eluted amount of retinoid decreases and the effect of retinoid decreases, or when it is very excessive, it may not be trapped inside porous silica and may exist on the surface of silica.

本發明還涉及一種化妝料組合物,其包含上述的表面改性的類視黃醇負載多孔二氧化矽。The present invention also relates to a cosmetic composition comprising the above-mentioned surface-modified retinoid-loaded porous silica.

類視黃醇使皮膚內成纖維細胞的增殖和膠原蛋白合成增加,因此本發明的化妝料組合物可用於皺紋功能性化妝品。Retinoids increase the proliferation of fibroblasts and collagen synthesis in the skin, so the cosmetic composition of the present invention can be used for functional cosmetics for wrinkles.

另外,本發明的表面改性的類視黃醇負載多孔二氧化矽可以以粉末形式用於O/W劑型。相對於100重量%的化妝料組合物,本發明的表面改性的類視黃醇負載多孔二氧化矽的含量可以為0.01至5重量%、更具體地0.05至4重量%。當超出上述範圍時,類視黃醇的效果不顯著,或者因過量使用而可對穩定性和安全性產生影響。In addition, the surface-modified retinoid-loaded porous silica of the present invention can be used in O/W dosage form in powder form. The content of the surface-modified retinoid-supported porous silica of the present invention may be 0.01 to 5% by weight, more specifically 0.05 to 4% by weight, relative to 100% by weight of the cosmetic composition. When the above range is exceeded, the effect of the retinoid is not significant, or the stability and safety may be affected due to excessive use.

本發明的化妝料組合物可以製備成一般的乳化劑型或可溶化劑型的化妝品形式。例如,可以具有諸如柔膚水或營養化妝水等化妝水,諸如面部露 (facial lotion)、身體露 (body lotion)等乳液,諸如營養霜、保濕霜、眼霜等霜,精華液,化妝軟膏,噴霧,凝膠,面膜,防曬霜,妝前底乳,液體型、固體型或噴霧型等的粉底,粉,諸如清潔霜 (cleansing cream)、清潔露(cleansing lotion)、清潔油(cleansing oil)等卸妝劑,諸如清潔泡沫、皂、沐浴露等洗滌劑等的劑型。The cosmetic composition of the present invention can be prepared as a general emulsified formulation or a solubilized formulation. For example, there may be lotions such as skin toner or nourishing lotion, lotions such as facial lotion and body lotion, creams such as nourishing cream, moisturizing cream, eye cream, essence, cosmetic ointment, Spray, gel, mask, sunscreen, primer, liquid, solid or spray foundation, powder, such as cleansing cream, cleansing lotion, cleansing oil and other makeup removers, such as cleansing foam, soap, body wash and other detergents.

另外,本發明的化妝料組合物可以含有化妝品學領域中通常使用的輔助劑,例如脂肪物質、有機溶劑、增溶劑、濃縮劑和膠凝劑、軟化劑、抗氧化劑、懸浮劑、穩定劑、發泡劑 (foaming agent)、芳香劑、表面活性劑、水、離子型或非離子型乳化劑、填充劑、金屬離子封鎖劑和螯合劑、保存劑、維生素、阻斷劑、潤濕劑、必需油、染料、顏料、親水性或親油性活性劑、脂質小囊或化妝品中通常使用的任意其他成分作為在製備一般化妝料組合物時所使用的輔助成分。In addition, the cosmetic composition of the present invention may contain adjuvants commonly used in the field of cosmetics, such as fatty substances, organic solvents, solubilizers, concentrating and gelling agents, emollients, antioxidants, suspending agents, stabilizers, Foaming agent, fragrance, surfactant, water, ionic or nonionic emulsifier, filler, metal ion blocker and chelating agent, preservative, vitamin, blocking agent, wetting agent, Essential oils, dyes, pigments, hydrophilic or lipophilic active agents, lipid vesicles or any other ingredients commonly used in cosmetics are used as auxiliary ingredients in the preparation of general cosmetic compositions.

根據本發明的一個具體例,本發明的表面改性的類視黃醇負載多孔二氧化矽可以以粉末形式用於O/W劑型,並且O/W劑型可以通過根據下表2的組成在75 ℃下使油相和水相成分完全溶解,然後利用均質混合機進行一次乳化,並且在45 ℃下投入本發明的表面改性的類視黃醇負載多孔二氧化矽粉末,進行二次乳化來製備。According to a specific example of the present invention, the surface-modified retinoid-loaded porous silica of the present invention can be used in O/W dosage form in powder form, and the O/W dosage form can be formulated according to the following Table 2 at 75 Dissolve the oil phase and water phase components completely at ℃, and then use a homomixer to perform primary emulsification, and add the surface-modified retinoid-loaded porous silica powder of the present invention at 45 °C for secondary emulsification. preparation.

實施方式Implementation

以下,通過根據本發明的實施例更詳細地說明本發明,但本發明的範圍不限於以下給出的實施例。Hereinafter, the present invention will be described in more detail through examples according to the present invention, but the scope of the present invention is not limited to the examples given below.

<實施例1>至<實施例4>表面改性的類視黃醇負載多孔二氧化矽粉末製備及應用劑型<Example 1> to <Example 4> Surface-modified retinoid-loaded porous silica powder preparation and application dosage form

用於製備表面改性的類視黃醇負載多孔二氧化矽的類視黃醇使用聚乙氧基化視黃醯胺。如表1的組成所示,在光阻斷條件下將類視黃醇和乙醇均勻溶解,然後利用亨舍爾混合機在多孔二氧化矽中緩慢投入製成的類視黃醇溶液,並均勻混合10分鐘。多孔二氧化矽的尺寸使用1~50 μm的直徑,多孔二氧化矽的吸油量使用0.3~3 cc/g水平的原料。將三乙氧基辛基矽烷 (triethoxycaprylylsilane)投入到一次製成的粉末中並利用亨舍爾混合機均勻混合10分鐘。為了表面處理,在約100 ℃下反應4小時以實施表面處理反應,然後冷卻,最終獲得表面改性的類視黃醇負載多孔二氧化矽粉末。The retinoid used to prepare the surface-modified retinoid-loaded porous silica used polyethoxylated retinamide. As shown in the composition of Table 1, the retinoid and ethanol were uniformly dissolved under light-blocking conditions, and then the prepared retinoid solution was slowly poured into the porous silica using a Henschel mixer and mixed uniformly 10 minutes. The size of the porous silica uses a diameter of 1 to 50 μm, and the oil absorption of the porous silica uses a material at the level of 0.3 to 3 cc/g. Put triethoxycaprylylsilane (triethoxycaprylylsilane) into the powder made at one time and mix uniformly for 10 minutes with a Henschel mixer. For surface treatment, react at about 100° C. for 4 hours to implement the surface treatment reaction, and then cool to finally obtain surface-modified retinoid-loaded porous silica powder.

將製成的類視黃醇負載多孔二氧化矽粉末應用於實際O/W劑型,組成如表2所示。製備方法通過在75 ℃下使油相和水相完全溶解,然後利用均質混合機進行一次乳化來製備,並且類視黃醇和類視黃醇多孔二氧化矽粉末在45 ℃下投入後,進行二次乳化。The prepared retinoid-loaded porous silica powder was applied to the actual O/W dosage form, and the composition is shown in Table 2. The preparation method is prepared by completely dissolving the oil phase and the water phase at 75 ° C, and then using a homomixer to perform primary emulsification, and after putting the retinoid and retinoid porous silica powder at 45 ° C, carry out secondary emulsification. secondary emulsification.

[表1] 類視黃醇多孔二氧化矽粉末組成和表面處理劑組成(重量%) 組成 比較例1 比較例2 比較例3 實施例1 實施例2 實施例3 類視黃醇 (聚乙氧基化視黃醯胺) 10 10 - 10 10 10 視黃醇 - - 10 - - - 多孔二氧化矽 - 70 70 70 70 70 表面處理劑(三乙氧基辛基矽烷) - - 7 2 5 7 乙醇 餘量 餘量 餘量 餘量 餘量 餘量 [Table 1] Retinoid Porous Silica Powder Composition and Surface Treatment Agent Composition (% by weight) composition Comparative example 1 Comparative example 2 Comparative example 3 Example 1 Example 2 Example 3 Retinoids (polyethoxylated retinamides) 10 10 - 10 10 10 Retinol - - 10 - - - porous silica - 70 70 70 70 70 Surface treatment agent (triethoxyoctylsilane) - - 7 2 5 7 ethanol margin margin margin margin margin margin

本發明中使用的類視黃醇利用(株)LSchem製造的Medimin A(平均分子量831),多孔二氧化矽使用SUNJIN BEAUTY SCIENCE製造的sunsil-130,表面處理劑使用shinetsu公司的AES原料,視黃醇使用BASF公司的Retinol 50C。The retinoid used in the present invention is Medimin A (average molecular weight 831) manufactured by LSchem Co., Ltd., the porous silica is sunsil-130 manufactured by SUNJIN BEAUTY SCIENCE, and the surface treatment agent is AES raw material of Shinetsu Corporation. As the alcohol, Retinol 50C from BASF was used.

[表2] 類視黃醇多孔二氧化矽粉末應用O/W劑型組成(重量%) 組成 比較例4 比較例5 實施例4 鯨蠟硬脂醇 2.25 2.25 2.25 甘油硬脂酸酯 0.5 0.5 0.5 硬脂酸 0.5 0.5 0.5 澳洲堅果籽油 10 10 10 PEG-40硬脂酸酯 1 1 1 脫水山梨醇硬脂酸酯 1 1 1 聚二甲基矽氧烷 5 5 5 純淨水 餘量 餘量 餘量 甘油 25 25 25 1,2-己二醇 2 2 2 黃原膠 0.1 0.1 0.1 聚丙烯酸酯交聯聚合物-6 0.1 0.1 0.1 甘草酸二鉀 0.2 0.2 0.2 比較例2(無表面處理) - 5 - 實施例3(有表面處理) - - 5 類視黃醇 0.5 - - [Table 2] Retinoid porous silica powder application O/W dosage form composition (weight %) composition Comparative example 4 Comparative Example 5 Example 4 cetearyl alcohol 2.25 2.25 2.25 Glyceryl Stearate 0.5 0.5 0.5 stearic acid 0.5 0.5 0.5 Macadamia Seed Oil 10 10 10 PEG-40 stearate 1 1 1 Sorbitan Stearate 1 1 1 Polydimethylsiloxane 5 5 5 pure water margin margin margin glycerin 25 25 25 1,2-Hexanediol 2 2 2 xanthan gum 0.1 0.1 0.1 Polyacrylate Crosspolymer-6 0.1 0.1 0.1 Dipotassium glycyrrhizinate 0.2 0.2 0.2 Comparative example 2 (no surface treatment) - 5 - Embodiment 3 (surface treatment is arranged) - - 5 Retinoids 0.5 - -

<實驗例1> 視黃醇/類視黃醇變色比較實驗<Experimental example 1> Retinol/retinoid discoloration comparative experiment

將矽烷類化合物投入到負載有聚乙氧基化類視黃醇的多孔二氧化矽(實施例3)中,利用亨舍爾混合機均勻分散,然後在熱處理溫度條件下反應4小時後獲得的粉末如表3所示。如比較例3所示,對於視黃醇,在熱處理時發生變色,相反對於實施例3,在熱處理溫度為100 ℃時獲得淡黃色的粉末。相反,在130 ℃以上的高溫下進行熱處理時獲得橙色的粉末。The silane compound is put into the porous silica loaded with polyethoxylated retinoid (Example 3), uniformly dispersed by Henschel mixer, and then reacted under heat treatment temperature for 4 hours to obtain The powders are shown in Table 3. As shown in Comparative Example 3, in the case of retinol, discoloration occurred upon heat treatment, whereas in Example 3, a pale yellow powder was obtained when the heat treatment temperature was 100°C. On the contrary, an orange powder is obtained when heat treatment is performed at high temperature above 130 °C.

[表3]

Figure 02_image001
[table 3]
Figure 02_image001

<實驗例2> 類視黃醇穩定性改善效果<Experimental example 2> Retinoid stability improvement effect

為了確認類視黃醇的穩定性,對純類視黃醇(比較例4)、類視黃醇負載多孔二氧化矽粉末應用劑型(比較例5)、表面改性的類視黃醇負載多孔二氧化矽粉末應用劑型(實施例4)實施了按經時的滴度 (titer)分析。In order to confirm the stability of retinoid, pure retinoid (comparative example 4), retinoid-loaded porous silica powder application formulation (comparative example 5), surface-modified retinoid-loaded porous The silica powder application dosage form (Example 4) was subjected to titer analysis over time.

如表4所示,可以確認穩定性按比較例4<比較例5=實施例4的順序得到改善。As shown in Table 4, it was confirmed that the stability was improved in the order of Comparative Example 4<Comparative Example 5=Example 4.

[表4] 類視黃醇穩定性比較    比較例4 比較例5 實施例4 4周 25 ℃ 100 100 100 40 ℃ 100 100 100 16周 25 ℃ 82.69 100 100 40 ℃ 71.15 100 100 [Table 4] Retinoid Stability Comparison Comparative example 4 Comparative Example 5 Example 4 4 weeks 25°C 100 100 100 40°C 100 100 100 16 weeks 25°C 82.69 100 100 40°C 71.15 100 100

<實驗例3> 作為用於改善安全性的緩釋型藥物遞送體的類視黃醇溶出行為實驗(按溶劑條件的類視黃醇溶出行為實驗)<Experimental Example 3> Dissolution behavior test of retinoid as a sustained-release drug delivery body for improving safety (dissolution behavior test of retinoid according to solvent conditions)

為了觀察類視黃醇的釋放行為,利用化妝品中常用的溶劑對比較例2和實施例1~3實施了第一次溶出實驗。作為溶劑使用了1,3-丁二醇 (1,3-butylene glycol),並且將比較例2和實施例1~3號粉末在溶劑中分散5%後,在一周內在振盪培養箱 (shaking incubator)中溶出一周。一周後,僅分析溶劑的上清液,計算溶出量。In order to observe the release behavior of retinoids, the first dissolution test was carried out for Comparative Example 2 and Examples 1 to 3 using solvents commonly used in cosmetics. 1,3-butanediol (1,3-butylene glycol) was used as the solvent, and after the powders of Comparative Example 2 and Examples 1 to 3 were dispersed in the solvent by 5%, they were placed in a shaking incubator (shaking incubator) within one week. ) for one week. After one week, only the supernatant of the solvent was analyzed and the amount dissolved was calculated.

如表5所示,可以確認對於未進行表面處理的比較例2,類視黃醇全部溶出,對於經表面處理的實施例1~3,用緩釋型藥物遞送體緩慢溶出類視黃醇。另外,類視黃醇的溶出量依賴於三乙氧基辛基矽烷的濃度 (2~7%)而減少,由此確認了表面改性的類視黃醇多孔二氧化矽粉末具有作為緩釋型製劑的應用可能性。As shown in Table 5, it can be confirmed that in Comparative Example 2 without surface treatment, all the retinoids were eluted, and in Examples 1 to 3 with surface treatment, it was confirmed that the retinoids were slowly eluted with the sustained-release drug delivery body. In addition, the amount of elution of retinoid decreased depending on the concentration of triethoxyoctylsilane (2~7%), thus confirming that the surface-modified retinoid porous silica powder has the function of sustained release. Possibility of application of formulations.

[表5] 類視黃醇溶劑溶出量(%)測試    溶出量(%) 比較例2 100% 實施例1 92% 實施例2 49% 實施例3 38% (在O/W劑型中的類視黃醇釋放行為實驗) [Table 5] Retinoid Solvent Dissolution (%) Test Dissolution (%) Comparative example 2 100% Example 1 92% Example 2 49% Example 3 38% (Retinoid Release Behavior Experiment in O/W Dosage Form)

為了確認在實際化妝品劑型中的類視黃醇溶出行為以及皮膚滲透,通過弗朗茲擴散池 (Franze diffusion cell)實驗比較了比較例4的劑型和應用溶出量最低的實施例3的實施例4劑型。皮膚滲透裝置使用如下圖所示的裝置,皮膚滲透裝置由供體室 (donor chamber)和受體室 (receptor chamber)構成,將皮膚置於其間然後固定(參考圖2)。在相同的試驗中使用的各池 (cell)具有2.54 cm 2的相同的表面積。將準備好的皮膚固定於皮膚滲透裝置以使角質層 (stratum corneum)向上定位。受體室的水溶液量為2.4 mL,並以300 rpm進行攪拌以使不影響試驗物質的擴散。本試驗中的類視黃醇的濃度設定為196.85 μg/cm 2並使用。為了維持皮膚內最大吸收率而應用的劑型的量為39.370 μl/cm 2以維持一定的皮膚吸收狀態,並均勻塗抹於皮膚上。試驗物質塗抹後,在6小時/24小時實驗結束的時間點採集皮膚,確定皮膚吸收率。 In order to confirm the retinoid dissolution behavior and skin penetration in the actual cosmetic dosage form, the dosage form of Comparative Example 4 was compared with Example 4 with the lowest dissolution amount of Example 3 by using a Franz diffusion cell experiment. dosage form. The skin penetration device uses the device shown in the figure below. The skin penetration device is composed of a donor chamber and a receptor chamber, and the skin is placed between them and then fixed (see Figure 2). Each cell used in the same experiment had the same surface area of 2.54 cm 2 . The prepared skin is secured to the skin penetration device with the stratum corneum positioned upwards. The volume of aqueous solution in the receptor chamber is 2.4 mL, and it is stirred at 300 rpm so as not to affect the diffusion of the test substance. The concentration of retinoid in this test was set at 196.85 μg/cm 2 and used. In order to maintain the maximum absorption rate in the skin, the amount of the dosage form applied is 39.370 μl/cm 2 to maintain a certain state of skin absorption, and evenly spread on the skin. After the test substance was applied, the skin was collected at the time point of the end of the 6-hour/24-hour experiment to determine the skin absorption rate.

如表6和7以及圖3和4所示,當比較6小時皮膚吸收量時,實施例4與比較例4相比,用緩釋型藥物遞送體溶出的類視黃醇的含量較少,但24小時皮膚吸收量比較結果,確認了與未負載於多孔二氧化矽的類視黃醇吸收相同量。因此,可以確認實施例4作為緩釋型製劑緩慢溶出類視黃醇,但以與未負載於多孔二氧化矽的類視黃醇類似的水平被吸收,並可以顯示出相同的功效/效果。As shown in Tables 6 and 7 and Figures 3 and 4, when comparing the 6-hour skin absorption amount, compared with Comparative Example 4 in Example 4, the content of the retinoid eluted with the sustained-release drug delivery body is less, However, as a result of comparing the amount of skin absorption in 24 hours, it was confirmed that the same amount was absorbed as retinoids not supported on porous silica. Therefore, it was confirmed that Example 4 elutes retinoid slowly as a sustained-release preparation, but is absorbed at a level similar to that of retinoid not supported on porous silica, and can exhibit the same efficacy/effect.

[表6] 利用弗朗茲擴散池的在O/W劑型中的類視黃醇釋放行為實驗(劑型體外皮膚吸收實驗結果)    比較例4 實施例4 皮膚殘留量(μg/cm 2) 58.886 56.739 皮膚滲透量(μg/cm 2) 2.349 2.314 皮膚吸收量(μg/cm 2) 61.235 59.053 皮膚吸收率(%) 31.107 29.999 [Table 6] Retinoid release behavior test in O/W dosage form using Franz diffusion cell (results of dosage form in vitro skin absorption test) Comparative example 4 Example 4 Skin residue (μg/cm 2 ) 58.886 56.739 Skin penetration (μg/cm 2 ) 2.349 2.314 Skin absorption (μg/cm 2 ) 61.235 59.053 Skin absorption rate (%) 31.107 29.999

[表7] 利用弗朗茲擴散池的在O/W劑型中的類視黃醇釋放行為實驗(按劑型應用時間的皮膚吸收量)    比較例4 實施例4 皮膚吸收量 (μg/cm 2) 6h 10.003 6.222 24h 61.235 59.053 皮膚吸收率(%) (24時間) 31.107 29.999 [Table 7] Retinoid release behavior test in O/W dosage form using Franz diffusion cell (skin absorption amount according to dosage form application time) Comparative example 4 Example 4 Skin absorption (μg/cm 2 ) 6 hours 10.003 6.222 24h 61.235 59.053 Skin absorption rate (%) (24 hours) 31.107 29.999

<實驗例4> 類視黃醇負載多孔二氧化矽粉末的安全性改善效果(體外HET-CAM測試)<Experimental Example 4> Safety improvement effect of retinoid-loaded porous silica powder (in vitro HET-CAM test)

通過受精卵 (fertile egg)眼黏膜刺激可能性評價,研究了安全性改善效果。使用的受精卵的物種和品系是白色來亨雞 (white leghorn, white egg)。為了檢查受精卵的敏感度,利用作為標準物質的特克斯邦 (Texapon)進行預備實驗,確定出血及溶血程度,並與實驗群進行比較。判斷刺激的標準分為弱刺激性 (slightly irritating)、中度刺激性 (moderately irritating)、刺激性 (irritating)、強刺激性 (severely irritating)並進行評價。為了確認表面改性的類視黃醇負載多孔二氧化矽粉末的安全性,對比較例1、實施例3樣品進行了HET-CAM測試。The safety improvement effect was studied by evaluating the possibility of ocular mucous membrane irritation of fertilized eggs. The species and strain of fertilized eggs used were white leghorn (white egg). In order to check the sensitivity of fertilized eggs, a preliminary experiment was carried out using Texapon as a standard substance to determine the degree of bleeding and hemolysis, and compared with the experimental group. The criteria for judging irritation are divided into slightly irritating, moderately irritating, irritating, and severely irritating and evaluated. In order to confirm the safety of the surface-modified retinoid-loaded porous silica powder, HET-CAM tests were carried out on the samples of Comparative Example 1 and Example 3.

如表8所示,確認了多孔二氧化矽負載及表面改性的實施例3樣品的刺激指數低於比較例1的刺激指數。As shown in Table 8, it was confirmed that the irritation index of the porous silica-supported and surface-modified sample of Example 3 was lower than that of Comparative Example 1.

[表8] HET-CAM測試刺激指數比較 實驗群 刺激指數 比較例1 8(中度刺激性,moderately irritating) 實施例3 4(弱刺激性,slightly irritating) [Table 8] HET-CAM Test Stimulation Index Comparison Experimental group stimulus index Comparative example 1 8 (moderately irritating) Example 3 4 (weakly irritating, slightly irritating)

(體內消費者品評測試)(In Vivo Consumer Tasting Test)

為了研究表面改性的類視黃醇多孔二氧化矽粉末的安全性改善效果,利用比較例5和實施例4樣品進行了消費者刺激品評測試。對於品評,以25名女性消費者為對象,晚上使用一次,使用一周後,進行最終刺激品評。刺激品評的尺度為5分尺度,分數越高,意味著刺激的強度越強。In order to study the safety improvement effect of the surface-modified retinoid porous silica powder, a consumer irritation test was carried out using the samples of Comparative Example 5 and Example 4. For evaluation, take 25 female consumers as objects, use it once in the evening, and conduct final stimulation evaluation after using it for a week. Stimulus evaluation scale is a 5-point scale, the higher the score, the stronger the intensity of the stimulus.

如圖5所示,比較例5和實施例4兩者均在2分以下,顯示出刺激較弱。As shown in FIG. 5 , both of Comparative Example 5 and Example 4 were 2 points or less, showing weak stimulation.

[產業利用可能性][Industrial Utilization Possibility]

本發明可以應用於穩定性和安全性得到改善的功能性化妝品領域。The present invention can be applied to the field of functional cosmetics with improved stability and safety.

[圖1]示出本發明的表面改性的類視黃醇負載多孔二氧化矽的製備製程。 [圖2]顯示利用弗朗茲擴散池 (Franze diffusion cell)的本發明的表面改性的類視黃醇負載多孔二氧化矽在O/W(水包油型,Oil in Water type)劑型中的類視黃醇釋放行為實驗結果,是劑型體外皮膚吸收實驗結果。 [圖3]和[圖4]顯示利用弗朗茲擴散池 (Franze diffusion cell)的本發明的表面改性的類視黃醇負載多孔二氧化矽在O/W劑型中的類視黃醇釋放行為實驗結果,是按劑型應用時間的皮膚吸收量結果。 [圖5]是本發明的表面改性的類視黃醇負載多孔二氧化矽的體內消費者品評測試結果。 [ Fig. 1 ] shows the production process of the surface-modified retinoid-supported porous silica of the present invention. [Fig. 2] Showing the surface-modified retinoid-loaded porous silica of the present invention in an O/W (Oil in Water type) dosage form using a Franze diffusion cell The results of the retinoid release behavior test are the results of the in vitro skin absorption test of the dosage form. [ FIG. 3 ] and [ FIG. 4 ] show the retinoid release of the surface-modified retinoid-loaded porous silica of the present invention in an O/W dosage form using a Franze diffusion cell The results of behavioral experiments are the results of skin absorption according to the application time of dosage forms. [ Fig. 5 ] is the in vivo consumer evaluation test result of the surface-modified retinoid-loaded porous silica of the present invention.

Claims (15)

一種類視黃醇負載多孔二氧化矽,其負載有聚乙氧基化類視黃醇並且由矽烷類化合物進行了表面改性。A retinoid-loaded porous silica loaded with polyethoxylated retinoid and surface-modified by silane compounds. 如請求項1所述的類視黃醇負載多孔二氧化矽,其中,該聚乙氧基化類視黃醇包含聚乙氧基化視黃醯胺 (polyethoxylated retinamide)。The retinoid-loaded porous silica according to claim 1, wherein the polyethoxylated retinoid comprises polyethoxylated retinamide. 如請求項1所述的類視黃醇負載多孔二氧化矽,其中,該多孔二氧化矽具有1至50 μm的直徑尺寸。The retinoid-loaded porous silica according to claim 1, wherein the porous silica has a diameter of 1 to 50 μm. 如請求項1所述的類視黃醇負載多孔二氧化矽,其中,該矽烷類化合物是選自由三乙氧基辛基矽烷 (Triethoxycaprylylsilane)、胺丙基三乙氧基矽烷 (Aminopropyl Triethoxysilane)、縮水甘油醚氧基丙基三甲氧基矽烷 (Glycidoxypropyl Trimethoxysilane)、異丁基三乙氧基矽烷 (Isobutyltriethoxysilane)、全氟辛基乙基三乙氧基矽烷 (Perfluorooctylethyl Triethoxysilane)、全氟辛基三乙氧基矽烷 (Perfluorooctyl Triethoxysilane)、硬脂基三乙氧基矽烷 (Stearyl Triethoxysilane)、甲基三乙氧基矽烷 (Methyltriethoxysilane)、PEG-8甲基醚三乙氧基矽烷 (PEG-8 Methyl Ether Triethoxysilane)和乙烯基乙氧基矽烷 (Vinyltriethoxysilane)組成的群組中的一種以上。The retinoid-loaded porous silica as described in claim 1, wherein the silane compound is selected from triethoxycaprylylsilane, aminopropyl triethoxysilane, Glycidoxypropyl Trimethoxysilane, Isobutyltriethoxysilane, Perfluorooctylethyl Triethoxysilane, Perfluorooctyltriethoxysilane Perfluorooctyl Triethoxysilane, Stearyl Triethoxysilane, Methyltriethoxysilane, PEG-8 Methyl Ether Triethoxysilane ) and Vinylethoxysilane (Vinylethoxysilane) in the group consisting of more than one. 如請求項1所述的類視黃醇負載多孔二氧化矽,其中,類視黃醇負載多孔二氧化矽通過混合聚乙氧基化類視黃醇溶液和多孔二氧化矽以將聚乙氧基化類視黃醇負載於多孔二氧化矽內,並且使負載有聚乙氧基化類視黃醇的多孔二氧化矽和矽烷類化合物反應以對多孔二氧化矽的表面進行改性而製備。The retinoid-loaded porous silica as described in claim 1, wherein the retinoid-loaded porous silica is mixed with polyethoxylated retinoid solution and porous silica to convert polyethoxylated Prepared by loading polyethoxylated retinoids in porous silica and reacting porous silica loaded with polyethoxylated retinoids with silane compounds to modify the surface of porous silica . 一種表面改性的類視黃醇負載多孔二氧化矽的製備方法,包括: 混合聚乙氧基化類視黃醇溶液和多孔二氧化矽以將聚乙氧基化類視黃醇負載於該多孔二氧化矽內的步驟;以及 使負載有該聚乙氧基化類視黃醇的該多孔二氧化矽和矽烷類化合物反應以對該多孔二氧化矽的表面進行改性的步驟。 A method for preparing surface-modified retinoid-loaded porous silica, comprising: a step of mixing the polyethoxylated retinoid solution and porous silica to load the polyethoxylated retinoid within the porous silica; and A step of modifying the surface of the porous silica by reacting the porous silica loaded with the polyethoxylated retinoid and a silane compound. 如請求項6所述的表面改性的類視黃醇負載多孔二氧化矽的製備方法,其中,該聚乙氧基化類視黃醇包含聚乙氧基化視黃醯胺 (polyethoxylated retinamide)。The method for preparing surface-modified retinoid-loaded porous silica as described in Claim 6, wherein the polyethoxylated retinoid comprises polyethoxylated retinamide (polyethoxylated retinamide) . 如請求項6所述的表面改性的類視黃醇負載多孔二氧化矽的製備方法,其中,該聚乙氧基化類視黃醇溶液通過在光阻斷條件下將該聚乙氧基化類視黃醇溶解在溶劑中而製備。The method for preparing surface-modified retinoid-loaded porous silica as described in Claim 6, wherein the polyethoxylated retinoid solution is prepared by adding polyethoxylated Prepared by dissolving retinoids in a solvent. 如請求項8所述的表面改性的類視黃醇負載多孔二氧化矽的製備方法,其中,該溶劑是甲醇或乙醇。The method for preparing surface-modified retinoid-loaded porous silica as claimed in item 8, wherein the solvent is methanol or ethanol. 如請求項6所述的表面改性的類視黃醇負載多孔二氧化矽的製備方法,其中,該聚乙氧基化類視黃醇溶液還包含選自由烴類油、酯油、天然油、矽油、抗氧化劑、光穩定劑、抗炎劑、防變色劑、紫外線阻斷劑、染料和顏料組成的群組中的一種以上。The method for preparing surface-modified retinoid-loaded porous silica as described in claim 6, wherein the polyethoxylated retinoid solution also contains a compound selected from hydrocarbon oil, ester oil, natural oil , silicone oil, antioxidant, light stabilizer, anti-inflammatory agent, anti-tarnish agent, UV blocker, dye and pigment group consisting of more than one. 如請求項6所述的表面改性的類視黃醇負載多孔二氧化矽的製備方法,其中,該多孔二氧化矽具有1至50 μm的直徑尺寸。The method for preparing surface-modified retinoid-loaded porous silica according to claim 6, wherein the porous silica has a diameter of 1 to 50 μm. 如請求項6所述的表面改性的類視黃醇負載多孔二氧化矽的製備方法,其中,負載有該聚乙氧基化類視黃醇的該多孔二氧化矽和該矽烷類化合物的反應在40至120 ℃下進行30分鐘至5小時。The method for preparing surface-modified retinoid-loaded porous silica as described in claim 6, wherein the porous silica loaded with the polyethoxylated retinoid and the silane compound are The reaction is carried out at 40 to 120°C for 30 minutes to 5 hours. 如請求項6所述的表面改性的類視黃醇負載多孔二氧化矽的製備方法,其中,該矽烷類化合物是選自由三乙氧基辛基矽烷 (Triethoxycaprylylsilane)、胺丙基三乙氧基矽烷 (Aminopropyl Triethoxysilane)、縮水甘油醚氧基丙基三甲氧基矽烷 (Glycidoxypropyl Trimethoxysilane)、異丁基三乙氧基矽烷 (Isobutyltriethoxysilane)、全氟辛基乙基三乙氧基矽烷 (Perfluorooctylethyl Triethoxysilane)、全氟辛基三乙氧基矽烷 (Perfluorooctyl Triethoxysilane)、硬脂基三乙氧基矽烷 (Stearyl Triethoxysilane)、甲基三乙氧基矽烷 (Methyltriethoxysilane)、PEG-8甲基醚三乙氧基矽烷 (PEG-8 Methyl Ether Triethoxysilane)和乙烯基乙氧基矽烷 (Vinyltriethoxysilane)組成的群組中的一種以上。The preparation method of surface-modified retinoid-loaded porous silica as described in claim 6, wherein the silane compound is selected from triethoxycaprylylsilane (Triethoxycaprylylsilane), aminopropyltriethoxy Aminopropyl Triethoxysilane, Glycidoxypropyl Trimethoxysilane, Isobutyltriethoxysilane, Perfluorooctylethyl Triethoxysilane , Perfluorooctyl Triethoxysilane (Perfluorooctyl Triethoxysilane), Stearyl Triethoxysilane (Stearyl Triethoxysilane), Methyltriethoxysilane (Methyltriethoxysilane), PEG-8 methyl ether triethoxysilane (PEG-8 Methyl Ether Triethoxysilane) and Vinylethoxysilane (Vinyltriethoxysilane) group consisting of more than one. 如請求項6所述的表面改性的類視黃醇負載多孔二氧化矽的製備方法,其中,相對於100重量%的表面改性的類視黃醇負載多孔二氧化矽,矽烷類化合物的混合量為0.5至20重量%。The method for preparing surface-modified retinoid-loaded porous silica as described in Claim 6, wherein, relative to 100% by weight of the surface-modified retinoid-loaded porous silica, the amount of silane compound The blending amount is 0.5 to 20% by weight. 一種化妝料組合物,其包含如請求項1所述的表面改性的類視黃醇負載多孔二氧化矽。A cosmetic composition comprising the surface-modified retinoid-loaded porous silica as described in Claim 1.
TW111123770A 2021-06-29 2022-06-24 Surface modified retinoid immersion porous silica TW202317065A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020210084952A KR102697264B1 (en) 2021-06-29 2021-06-29 Surface modified retinoid immersion porous silica
KR10-2021-0084952 2021-06-29

Publications (1)

Publication Number Publication Date
TW202317065A true TW202317065A (en) 2023-05-01

Family

ID=84692900

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111123770A TW202317065A (en) 2021-06-29 2022-06-24 Surface modified retinoid immersion porous silica

Country Status (5)

Country Link
JP (1) JP2024525049A (en)
KR (1) KR102697264B1 (en)
CN (1) CN115531230A (en)
TW (1) TW202317065A (en)
WO (1) WO2023277479A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100589957B1 (en) * 1998-12-31 2007-04-25 주식회사 엘지생활건강 Anti-aging cosmetic composition containing polyethoxylated retinamide
KR100768113B1 (en) * 2005-12-02 2007-10-18 주식회사 케미랜드 Powder type cosmetic composition
US20120156268A1 (en) * 2009-06-19 2012-06-21 U.S. Cosmetics Corporation Cosmetic compositions and methods for enhanced uv protection
KR101346792B1 (en) * 2010-09-03 2014-01-02 주식회사 엘지생활건강 Cosmetic composition for improving skin wrinkle comprising polyethoxylated retinamide in nanoliposome comprising UV absorber
KR101314100B1 (en) 2011-07-12 2013-10-04 (주)에이씨티 Stabilizing method of an unstable retinol using nanoparticles of silica coated lipid monolayer shell and biodegradable polymer core and cosmetic composition containing the same
KR102195983B1 (en) * 2019-08-28 2020-12-30 주식회사 비제이바이오켐 Method for producing a cosmetic composition comprising silica ceramide composite

Also Published As

Publication number Publication date
KR102697264B1 (en) 2024-08-22
KR20230001874A (en) 2023-01-05
JP2024525049A (en) 2024-07-09
CN115531230A (en) 2022-12-30
WO2023277479A1 (en) 2023-01-05

Similar Documents

Publication Publication Date Title
RU2537235C2 (en) Mildly acting indelible compositions for skin care
CN114073644B (en) Cosmetic composition containing capsules
JP2003527411A (en) Method for preparing a high pressure / high shear dispersion containing a physiologically active ingredient
KR101145060B1 (en) O/W cosmetic composition having improved cosmetics formulation stability
TW200800276A (en) Silicone-in-water emulsion compositions containing retinoids
CN110772442B (en) Cosmetic composition comprising eutectic mixture
WO2006041782A1 (en) Conversion of liquid compositions to a powder
CN105408301A (en) Ultraviolet absorbent having better ultraviolet protection effect, and combination thereof
JPH08283303A (en) Emulsifier comprising higher fatty acid dextrin, emulsion composition containing the same, and cosmetic
JPH0739336B2 (en) Stabilized clathrate compound and cosmetics containing the same
JP2004284988A (en) Hair cosmetic and method for inhibiting carbonylation of hair protein
TW202317065A (en) Surface modified retinoid immersion porous silica
US8815267B2 (en) Hybrid powder of halloysite nanotube and light-scattering nanoparticle, method for preparing the same, and UV-screening cosmetic composition containing the same as active ingredient
EP3708141A1 (en) Method for treating hair with a cosmetic composition comprising particles of hydrophobic silica aerogel and a specific acrylic thickening polymer
JP2018177757A (en) Cosmetic
JP4300105B2 (en) Antioxidant
JP6591960B2 (en) Alkoxylated fatty alcohol alkyl ethers and products containing the same
JPH07196466A (en) Cosmetic composition formulated with tea powder
KR100681704B1 (en) Water-in-oil type cosmetic composition comprising fatty acid and cellulose alkyl ether
JP2009084243A (en) Horny layer hyaluronic acid production accelerator and external dermatological preparation, cosmetic, and quasi-drug containing horny layer hyaluronic acid production accelerator
JP2006282536A (en) Super oxide-eliminating agent, free radical-eliminating agent, hydrogen peroxide-eliminating agent and external preparation for skin
JP2522803B2 (en) Cosmetics
KR102695333B1 (en) Oil drop type cosmetic composition
KR102294435B1 (en) A cosmetic composition
EP4349317A1 (en) Stable dispersions of titanium dioxide and/or zinc oxide